Showing 1 - 6 results of 6 for search 'Mutsuko Kukimoto-Niino', query time: 0.03s Refine Results
  1. 1
    RhoG-Binding Domain of Elmo1 Ameliorates Excessive Process Elongation Induced by Autism Spectrum Disorder-Associated Sema5A

    RhoG-Binding Domain of Elmo1 Ameliorates Excessive Process Elongation Induced by Autism Spectrum Disorder-Associated Sema5A by Miyu Okabe, Yuki Miyamoto, Yuta Ikoma, Mikito Takahashi, Remina Shirai, Mutsuko Kukimoto-Niino, Mikako Shirouzu, Junji Yamauchi

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Autism Spectrum Disorder- and/or Intellectual Disability-Associated Semaphorin-5A Exploits the Mechanism by Which Dock5 Signalosome Molecules Control Cell Shape

    Autism Spectrum Disorder- and/or Intellectual Disability-Associated Semaphorin-5A Exploits the Mechanism by Which Dock5 Signalosome Molecules Control Cell Shape by Miyu Okabe, Takanari Sato, Mikito Takahashi, Asahi Honjo, Maho Okawa, Miki Ishida, Mutsuko Kukimoto-Niino, Mikako Shirouzu, Yuki Miyamoto, Junji Yamauchi

    Published 2024-04-01
    Get full text
    Article
  3. 3
    Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN

    Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN by Kanako Shimizu, Satoru Yamasaki, Maki Sakurai, Noriko Yumoto, Mariko Ikeda, Chiemi Mishima-Tsumagari, Mutsuko Kukimoto-Niino, Takashi Watanabe, Masami Kawamura, Mikako Shirouzu, Shin-ichiro Fujii

    Published 2019-06-01
    Get full text
    Article
  4. 4
    Targeting Ras-binding domain of ELMO1 by computational nanobody design

    Targeting Ras-binding domain of ELMO1 by computational nanobody design by Chunlai Tam, Mutsuko Kukimoto-Niino, Yukako Miyata-Yabuki, Kengo Tsuda, Chiemi Mishima-Tsumagari, Kentaro Ihara, Mio Inoue, Mayumi Yonemochi, Kazuharu Hanada, Takehisa Matsumoto, Mikako Shirouzu, Kam Y. J. Zhang

    Published 2023-03-01
    Get full text
    Article
  5. 5
    A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer

    A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer by Mai Suzuki, Ken Uchibori, Tomoko Oh-hara, Yumi Nomura, Ryusei Suzuki, Ai Takemoto, Mitsugu Araki, Shigeyuki Matsumoto, Yukari Sagae, Mutsuko Kukimoto-Niino, Yusuke Kawase, Mikako Shirouzu, Yasushi Okuno, Makoto Nishio, Naoya Fujita, Ryohei Katayama

    Published 2024-02-01
    Get full text
    Article
  6. 6
    A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor

    A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor by Yutaka Furutani, Yoshinori Hirano, Mariko Toguchi, Shoko Higuchi, Xian-Yang Qin, Kaori Yanaka, Yumi Sato-Shiozaki, Nobuaki Takahashi, Marina Sakai, Pornparn Kongpracha, Takehiro Suzuki, Naoshi Dohmae, Mutsuko Kukimoto-Niino, Mikako Shirouzu, Shushi Nagamori, Harukazu Suzuki, Kaoru Kobayashi, Takahiro Masaki, Hiroo Koyama, Kazuma Sekiba, Motoyuki Otsuka, Kazuhiko Koike, Michinori Kohara, Soichi Kojima, Hideaki Kakeya, Tomokazu Matsuura

    Published 2023-12-01
    Get full text
    Article

Search Tools: